SEATTLE, Feb. 21, 2019 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global blood dialyzer market was valued at US$ 4.68 billion in 2016 and is projected to exhibit a CAGR of 6.1% during the forecast period (2018 – 2026).
Key Trends and Analysis of the Blood Dialyzer Market:
Manufacturers are engaged in intensifying their services by expanding manufacturing units, and joint ventures. For instance, in December 2017, Nikkiso Co. Ltd. of Japan partnered with China based, Shandong Weigao Group Medical Polymer Company, to increase production of dialyzers in China by fivefold by 2020, and raise its output to 20,000 units every year.
Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/2503
Moreover, significant increase in the number of U.S. Food and Drug Administration (USFDA) approvals for blood dialyzers will aid in growth of the market. For instance, in June 2018, USFDA permitted marketing of two catheter-based dialyzers, Ellipsys Vascular Access system and everlinQ endoAVF system, which are designed to create a connection to veins and arteries in patients with chronic kidney disease who need hemodialysis. Such approvals are positively impacting the overall market growth.
Prevalence of kidney diseases is increasing globally, due to rising geriatric population, urinary disorders, and changing lifestyles. According to United Nations, Department of Economic and Social Affairs, Population Division, the global population aged 60 and above increased by 68% in urban areas and by 25% in the rural areas, between 2000 and 2015. Rising geriatric population will increase the chances for kidney diseases, which will be influencing favorably for sustained growth of the blood dialyzer market over the next decade.
Additionally, rising government initiatives to advance improved treatment options for patients with kidney failure aids manufacturers to gain substantial growth in the global blood dialyzer market. For instance, in September 2018, the U.S. Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN) held a prize money of US $ 2,265,000 for KidneyX: Redesign Dialysis. This competition challenges manufacturers to develop better treatment options for patients with kidney failure. Thus, HHS is expecting innovations in the field of dialysis and dialyzer membranes to redesign treatment for kidney failure.
To know the latest trends and insights prevalent in this market, click the link below:
https://www.coherentmarketinsights.com/market-insight/blood-dialyzer-market-2503
Key Market Takeaways:
- The global blood dialyzer market is expected to expand at a CAGR of 6.1% during the forecast period (2018 – 2026), owing to continuous technological advancements in dialyzers membrane.
- Based on product type, disposable dialyzers are expected to receive maximum growth, owing to risks associated with reusable dialyzers.
- On the basis of dialysis membrane material, synthetic cellulose segment is expected to perceive maximum traction owing to new product launches. For instance, in November 2017, Nipro Medical Corporation announced the launch of Cellentia-H cellulose triacetate (CTA), a single-use dialyzer at the 2017 ASN Kidney Week Conference. The cellulose triacetate membrane optimizes excellent biocompatibility and clearances to minimize potential adverse reactions. The Cellentia-H is also gamma sterilized to enhance product safety and sterility. Such technology advancements in blood dialyzers promote its growth in the global market during the forecast period.
- Major players operating in the global blood dialyzer market include Baxter International, Inc., Nikkiso Co. Ltd., B. Braun Medical Inc., Nipro Corporation, CVS Health., Diaverum Deutschland GmbH, NxStage Medical, Inc., Fresenius Medical Care AG & Co. KGaA, and DaVita Healthcare Partners, Inc.